Tech Digest

More Evidence That Aging Can Be Reversed

Stay Up to Date!

Simply enter your email below and click SIGN UP!

From Bioscience Expert Patrick Cox - The Most Life-Changing Book You'll Read This Year - Click Here

December 19, 2016

Dear Reader,

Two weeks ago, Michael West, PhD, gave a keynote address to the World Stem Cell Summit. In it, West said that he and his collaborators are learning to unlock powers in our genomes to reverse aging and repair even major injuries.

Last week, scientists from the prestigious Salk Institute for Biological Studies presented evidence in the journal Cell that they are on track to doing the same thing.

That there are nearly simultaneous announcements by two respected but independent groups of scientists is momentous. Still, West’s presentation garnered almost no attention outside of the scientific community. The Salk Institute generated some media coverage, but not as much as it deserved.

In a more rational world, the conjunction of these two group’s announcements would have dominated the news headlines.


If they’re correct, it is the end of the frailty and diseases associated with old age. More dramatically, it’s the elimination of maximum life spans (currently about 120 years).

Neither West nor Dr. Juan Carlos Izpisua Belmonte, the lead investigator of the Salk team, have said this as bluntly as I have—but it’s entirely understandable that they haven’t.

I’ve been following this field of research for years. I also speak on a regular basis to groups of investors about biotech and usually bring it up. Typically, almost nobody seems to hear what I say.

Part of the problem is that age reversal just seems too good to be true. It’s like magic, and magic isn’t real. I understand that people are skeptical (though the two events described at the beginning of this article may help change that). Also, very few people are psychologically capable of processing the possibility of ageless individuals and societies.

This is not unique to the layman. Most researchers in biogerontology are focused on geroprotection (anti-aging). This is a modest goal of slowing the aging processes through biochemical and behavioral therapies. It is now generally recognized that we can delay the breakdown of critical biological systems and keep people healthier longer.

From personal experience, I know that many gerontologists working on this goal disclaim radical life extension—efforts to make and keep people biologically young.

It’s understandable; it has taken scientists decades to convince regulators and the public that it makes more sense to prevent diseases than to treat them. Now that they’ve finally managed to gain some acceptance for that view, few of those scientists want their peers to complicate things by talking about genetically reversing aging.

The technology envisioned by West and Belmonte would change the human experience in ways that are nearly unfathomable, and they can expect considerable criticism from all sides.

In theory, however, age reversal is a pretty simple concept. It starts with understanding that the DNA of older humans (adults) has the power to produce biologically young offspring. Now you just have to realize that this ability lies dormant in the genes of nearly every cell in your body.

In the first few months of embryonic development (embryogenesis), a tiny clump of featureless cells turns into all the different parts and systems that make up whole human beings. During that time, the embryo has nearly superhuman regenerative capabilities. If an embryo is damaged, it doesn’t scar. It heals entirely, even growing new organs and body parts.

At about two months, a genetic change takes place. At that point, embryonic cells become “adult” cells, though we usually refer to them as fetal cells.

In animals, we already know that it is now possible to restore the remarkable abilities we see in the embryogenesis stage. West and Belmonte are working on making this true for humans as well.

While their specific approaches are slightly different, both scientists aim to accomplish the same thing: reactivate the embryonic abilities hidden in adult genomes to create complex, healthy, and young tissues, limbs, and organs. Both research groups believe, bolstered by considerable evidence, that a simple combination of gene-activating small-molecule drugs could restore embryonic healing powers in adults.

This is the biggest news ever.

Long after the political controversies that journalists obsess over are forgotten, the dawning of age reversal will be remembered. Moreover, those who refuse to ponder the possibility that it will happen may find themselves unprepared for the biggest transformation in the history of mankind.

Patrick Cox
Patrick Cox
Editor, Transformational Technology Alert

Mauldin Economics


Stay in the Loop on Life-Extending Research
with Patrick Cox's Tech Digest

Tech Digest

Your privacy is very important to us. Please review our Privacy Policy.


« Back to Articles

From Bioscience Expert Patrick Cox - The Most Life-Changing Book You'll Read This Year - Click Here

Discuss This

We welcome your comments. Please comply with our Community Rules.


There are no comments at this time.

Use of this content, the Mauldin Economics website, and related sites and applications is provided under the Mauldin Economics Terms & Conditions of Use.

Unauthorized Disclosure Prohibited

The information provided in this publication is private, privileged, and confidential information, licensed for your sole individual use as a subscriber. Mauldin Economics reserves all rights to the content of this publication and related materials. Forwarding, copying, disseminating, or distributing this report in whole or in part, including substantial quotation of any portion the publication or any release of specific investment recommendations, is strictly prohibited.
Participation in such activity is grounds for immediate termination of all subscriptions of registered subscribers deemed to be involved at Mauldin Economics’ sole discretion, may violate the copyright laws of the United States, and may subject the violator to legal prosecution. Mauldin Economics reserves the right to monitor the use of this publication without disclosure by any electronic means it deems necessary and may change those means without notice at any time. If you have received this publication and are not the intended subscriber, please contact


The Mauldin Economics website, Yield Shark, Thoughts from the Frontline, Patrick Cox’s Tech Digest, Outside the Box, Over My Shoulder, World Money Analyst, Street Freak, ETF 20/20, Just One Trade, Transformational Technology Alert, Rational Bear, The 10th Man, Connecting the Dots, This Week in Geopolitics, Stray Reflections, and Conversations are published by Mauldin Economics, LLC. Information contained in such publications is obtained from sources believed to be reliable, but its accuracy cannot be guaranteed. The information contained in such publications is not intended to constitute individual investment advice and is not designed to meet your personal financial situation. The opinions expressed in such publications are those of the publisher and are subject to change without notice. The information in such publications may become outdated and there is no obligation to update any such information. You are advised to discuss with your financial advisers your investment options and whether any investment is suitable for your specific needs prior to making any investments.
John Mauldin, Mauldin Economics, LLC and other entities in which he has an interest, employees, officers, family, and associates may from time to time have positions in the securities or commodities covered in these publications or web site. Corporate policies are in effect that attempt to avoid potential conflicts of interest and resolve conflicts of interest that do arise in a timely fashion.
Mauldin Economics, LLC reserves the right to cancel any subscription at any time, and if it does so it will promptly refund to the subscriber the amount of the subscription payment previously received relating to the remaining subscription period. Cancellation of a subscription may result from any unauthorized use or reproduction or rebroadcast of any Mauldin Economics publication or website, any infringement or misappropriation of Mauldin Economics, LLC’s proprietary rights, or any other reason determined in the sole discretion of Mauldin Economics, LLC.

Affiliate Notice

Mauldin Economics has affiliate agreements in place that may include fee sharing. If you have a website or newsletter and would like to be considered for inclusion in the Mauldin Economics affiliate program, please go to Likewise, from time to time Mauldin Economics may engage in affiliate programs offered by other companies, though corporate policy firmly dictates that such agreements will have no influence on any product or service recommendations, nor alter the pricing that would otherwise be available in absence of such an agreement. As always, it is important that you do your own due diligence before transacting any business with any firm, for any product or service.

© Copyright 2018 Mauldin Economics